학술논문
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Document Type
Article
Author
Barrett, Jordan R.; Belij-Rammerstorfer, Sandra; Dold, Christina; Ewer, Katie J.; Folegatti, Pedro M.; Gilbride, Ciaran; Halkerston, Rachel; Hill, Jennifer; Jenkin, Daniel; Stockdale, Lisa; Verheul, Marije K.; Aley, Parvinder K.; Angus, Brian; Bellamy, Duncan; Berrie, Eleanor; Bibi, Sagida; Bittaye, Mustapha; Carroll, Miles W.; Cavell, Breeze; Clutterbuck, Elizabeth A.; Edwards, Nick; Flaxman, Amy; Fuskova, Michelle; Gorringe, Andrew; Hallis, Bassam; Kerridge, Simon; Lawrie, Alison M.; Linder, Aline; Liu, Xinxue; Madhavan, Meera; Makinson, Rebecca; Mellors, Jack; Minassian, Angela; Moore, Maria; Mujadidi, Yama; Plested, Emma; Poulton, Ian; Ramasamy, Maheshi N.; Robinson, Hannah; Rollier, Christine S.; Song, Rinn; Snape, Matthew D.; Tarrant, Richard; Taylor, Stephen; Thomas, Kelly M.; Voysey, Merryn; Watson, Marion E. E.; Wright, Daniel; Douglas, Alexander D.; Green, Catherine M.; Hill, Adrian V. S.; Lambe, Teresa; Gilbert, Sarah; Pollard, Andrew J.
Source
Nature Medicine; June 2021, Vol. 27 Issue: 6 p1113-1113, 1p
Subject
Language
ISSN
10788956; 1546170X
Abstract
A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01372-z.